Crandell Keith's Form 4 filing
Codiak BioSciences, Inc. (CDAK) · filed Sep 15, 2022
- Accession no.
- 0001062993-22-019586
- Filed
- Sep 15, 2022, 6:53 PM ET
- Trade date
- Sep 13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $7.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Bybee ClintonCIK 0001219043 | 10% Owner |
| ARCH Venture Fund VIII, L.P.CIK 0001605598 | 10% Owner |
| ARCH Venture Partners VIII, LLCCIK 0001616165 | 10% Owner |
| ARCH Venture Partners VIII, L.P.CIK 0001616176 | 10% Owner |
| ARCH Venture Fund VIII Overage, L.P.CIK 0001617237 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Sotck | PPurchaseAcquired | +5,000,000 | $1.50 | +$7,500,000 | 8,854,098 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Stock | PPurchaseAcquired | +5,000,000 | – | – | 5,000,000 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.